首页> 美国卫生研究院文献>other >Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity
【2h】

Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity

机译:次要抗原的细菌疫苗:am779是次优的无形体外膜疫苗但与保护豁免并不助理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Identification of specific antigens responsible for the ability of complex immunogens to induce protection is a major goal in development of bacterial vaccines. Much of the investigation has focused on highly abundant and highly immunodominant outer membrane proteins. Recently however, genomic and proteomic approaches have facilitated identification of minor components of the bacterial outer membrane that have previously been missed or ignored in immunological analyses. Immunization with Anaplasma marginale outer membranes or a cross-linked surface complex induces protection against bacteremia, however the components responsible for protection within these complex immunogens are unknown. Using outer membrane protein AM779 as a model, we demonstrated that this highly conserved but minor component of the A. marginale surface was immunologically sub-dominant in the context of the outer membrane or surface complex vaccines. Immunologic sub-dominance could be overcome by targeted vaccination with AM779 for T lymphocyte responses but not for antibody responses, suggesting that both abundance and intrinsic immunogenicity determine relative dominance. Importantly, immunization with AM779 supports that once priming is achieved by specific targeting, recall upon infectious challenge is achieved. While immunization with AM779 alone was not sufficient to induce protection, the ability of targeted immunization to prime the immune response to highly conserved but low abundance proteins supports continued investigation into the role of sub-dominant antigens, individually and collectively, in vaccine development for A. marginale and related bacterial pathogens.
机译:鉴定负责复杂免疫原诱导保护能力的特定抗原是细菌疫苗开发的主要目标。许多研究集中在高度丰富和高度免疫优势的外膜蛋白上。然而,最近,基因组学和蛋白质组学方法已经促进了细菌外膜的微量成分的鉴定,这些成分以前在免疫学分析中被遗漏或忽略。用Anaplasma marginale外膜或交联的表面复合物进行免疫诱导了针对菌血症的保护,但是在这些复合免疫原中负责保护的成分尚不清楚。使用外膜蛋白AM779作为模型,我们证明了在外膜或表面复合物疫苗的情况下,margin曲霉表面的高度保守但次要成分在免疫学上占主导地位。免疫性亚优势可以通过针对T淋巴细胞反应而不是抗体反应的AM779靶向疫苗来克服,这表明丰度和固有免疫原性都决定了相对优势。重要的是,用AM779进行免疫支持一旦通过特异性靶向实现了初免,就可以实现传染性攻击的召回。虽然仅用AM779免疫还不足以诱导保护作用,但针对性免疫针对高保守但低丰度蛋白引发免疫反应的能力支持继续研究亚主要抗原在A疫苗开发中的作用,无论是单独还是集体边缘和相关细菌病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号